Sinisa Mihajlovic was a famous footballer and coach of football, of Serbian origin but also with Italian citizenship. His roles were defender and midfielder.
Where did he play
Mihajlovic started at Vojvodina, a Serbian side based in Novi Sad, but was soon bought in 1990 by the Red Star , whereby won the Champions Cup just in the 1990/1991 season.
Already in 1992 he arrived at Rome with which he began to make history.
From there he moved on to Sampdoria and Lazio, up to to Inter which he left in 2006.
Where did he train
As a coach he started in 2006 at Inter as assistant coach, later continuing as principal in the Bologna. Then followed:
- Catania,
- Fiorentina
- Serbian national team
- Sampdoria
- Milan
- Torino
- Sporting Lisbon
- And Bologna again in 2019
What was he sick with: what is acute myeloid leukemia
Mihajlovic suffered from acute myeloid leukemia, diagnosed in 2019. In essence it is about a blood cancer which develops in the bone marrow, blood and lymphatic system.
He underwent a bone marrow transplant that year at Sant'Orsola in Bologna.
Bone marrow transplantation is the most efficient therapy and effective to treat this type of disease, also because it is the one that statistically it has a recurrence rate, i.e. return of the disease, more Bass.
Unfortunately that was not the case for Mihajlovic, as the disease has returned.
Bone marrow transplant is the most effective therapy to eradicate acute myeloid leukemia. In this moment it guarantees a lower possibility of recurrence: unfortunately in this case the disease has returned, it was very aggressive and was refractory to treatment
Francesca Bonifaci, director of the transplant program that followed Mihajlovic
Unfortunately, other therapies, even experimental ones, such as Car-T are not compatible with the type of leukemia he was suffering from and he was unable to use them.
currently Car-T cells they work for the skin leukemia, lymphoma or myeloma. They are different cases from that of Sinisa. As for the Car-T in acute myeloid leukemia we are still in an experimental phase. Sant'Orsola has applied to create a self-factory for the production of academic Car-t cells, but we are still at the beginning. We hope to win our bid and start building this one soon self-factory which will be hosted in the new hematology thanks to the Seragnoli Foundation
Francesca Bonifaci
